3 Key Ways to Reduce Patient Wait Times for Innovative Treatments: A Roadmap to Faster Healthcare Access | Blog, MARKET ACCESS 2024
In the complex landscape of Canadian healthcare, patients are losing their most precious resource: time. Karen Heim’s powerful presentation at the Market Access conference revealed a stark reality – patients in Canada wait nearly two years after Health Canada approval …...
7 Insider Secrets: How Manufacturers Can Navigate the New CDA Mandate | Blog, MARKET ACCESS 2024
The Canadian drug landscape is undergoing a transformative shift, and pharmaceutical manufacturers need a strategic playbook to succeed. Here are seven insider secrets to help you navigate the Canada’s Drug Agency’s (CDA) new mandate: 1. Embrace Real-World Evidence Early …...
4 Fresh Trends in Healthcare Technology for Equitable Access: Transforming Canadian Healthcare Delivery | Blog, MARKET ACCESS 2024
In a recent panel discussion on pharmaceutical access, healthcare experts revealed critical insights into how technology could revolutionize healthcare equity. Here are four groundbreaking trends that promise to reshape how Canadians access medical care: Intelligent Telehealth Beyond Urban Centers The …...
3 Key Ways Outcome-Based Agreements Can Revolutionize Healthcare Access | Blog, MARKET ACCESS 2024
In the rapidly evolving landscape of healthcare innovation, breakthrough therapies are emerging faster than ever—but there’s a critical bottleneck preventing patients from accessing these life-changing treatments. Enter Outcome-Based Agreements (OBAs), a strategic approach that’s poised to transform how we think …...
